Literature DB >> 8596065

Comparison between factor analysis of dynamic structures and Fourier analysis in detection of segmental wall motion abnormalities: a clinical evaluation.

F Cavaillolès1, J P Bazin, D Pavel, E Olea, M Faraggi, F Frouin, R Di Paola.   

Abstract

To evaluate Factor Analysis of Dynamic Structures (FADS) versus or in association with other methods, a protocol was set up including as 'gold standard' investigation the left ventricular angiography (LVA) and processing by Fourier Analysis (FA), and FADS with different variants. To refine the diagnosis of Regional Wall Motion Abnormalities (RWMA), processing was done on a sectorial basis for more accurate spatial localization and functional description. 53 patients were studied (8 normal, 45 with coronary artery disease). FADS gave better results than FA on a sectorial basis. Total agreement between FADS and LVA was obtained in 208/265 (78%), while FA was in agreement with LVA in only 167/265 segments (63%). Globally, FADS was significantly better than FA (Z-test: p < 0.05). When only the diagnosis of maximal abnormality was considered, FA and FADS are statistically equivalent. The superiority of FADS vs FA is more obvious in the diagnosis of hypokinesia. Most FA discrepancies corresponded to underestimation of WMA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8596065     DOI: 10.1007/bf01145195

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  6 in total

1.  Volume ejected in early systole. A sensitive index of left ventricular performance in coronary artery disease.

Authors:  L L Johnson; K Ellis; D Schmidt; M B Weiss; P J Cannon
Journal:  Circulation       Date:  1975-09       Impact factor: 29.690

2.  Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1968-10       Impact factor: 17.737

3.  Sectoranalysis of left ventricular function by fully automated equilibrium radionuclide ventriculography.

Authors:  R Standke; G Hör; H Klepzig; F D Maul; W D Bussmann; M Kaltenbach
Journal:  Int J Card Imaging       Date:  1985

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Factor analysis in gated cardiac studies.

Authors:  F Cavailloles; J P Bazin; R Di Paola
Journal:  J Nucl Med       Date:  1984-10       Impact factor: 10.057

6.  Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.

Authors:  L Manil; F Boudet; P Motte; P Gardet; J C Saccavini; J D Lumbroso; M Schlumberger; B Caillou; J P Bazin; M Ricard
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

  6 in total
  4 in total

1.  Cardiac gated equilibrium radionuclide angiography and multiharmonic Fourier phase analysis: optimal acquisition parameters in arrhythmogenic right ventricular cardiomyopathy.

Authors:  D Daou; R Lebtahi; M Faraggi; Y Petegnief; D Le Guludec
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

2.  Comparison of left ventricular systolic function and mechanical dyssynchrony using equilibrium radionuclide angiography in patients with right ventricular outflow tract versus right ventricular apical pacing: A prospective single-center study.

Authors:  Harmandeep Singh; Chetan D Patel; Gautam Sharma; Nitish Naik
Journal:  J Nucl Cardiol       Date:  2015-01-23       Impact factor: 5.952

3.  Automated Classification of Severity in Cardiac Dyssynchrony Merging Clinical Data and Mechanical Descriptors.

Authors:  Alejandro Santos-Díaz; Raquel Valdés-Cristerna; Enrique Vallejo; Salvador Hernández; Luis Jiménez-Ángeles
Journal:  Comput Math Methods Med       Date:  2017-02-19       Impact factor: 2.238

4.  Normality index of ventricular contraction based on a statistical model from FADS.

Authors:  Luis Jiménez-Ángeles; Raquel Valdés-Cristerna; Enrique Vallejo; David Bialostozky; Verónica Medina-Bañuelos
Journal:  Comput Math Methods Med       Date:  2013-03-24       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.